Uninterrupted direct-acting oral anticoagulation in patients undergoing transradial percutaneous coronary procedures: The DOAC-NOSTOP study rationale and design-Reference-Cited by-同舟云学术

Uninterrupted direct-acting oral anticoagulation in patients undergoing transradial percutaneous coronary procedures: The DOAC-NOSTOP study rationale and design

Published:2024-06 Issue: Volume:63 Page:68-72
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Teira Calderón Andrea,Chiarito Mauro,Santos Ignacio Amat,Cao Davide,Vaquerizo Montilla Beatriz,Jurado Román Alfonso,Pulido Garrido Paloma,Tartaglia Francesco,García-García Héctor M.,Díez-Gil Jose Luis,Sanz-Sánchez Jorge

Publisher

Elsevier BV

Reference31 articles.

1. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions;Lip;EP Europace,2019

2. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation;Steffel;Eur Heart J,2018

3. Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention;Kowalewski;Int J Cardiol,2016

4. Dewilde WJ, Oirbans T, Verheugt FW, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, andomized, controlled trial. The Lancet 2013;381(9872):1107–1115. Doi:https://doi.org/10.1016/S0140-6736(12)62177-1.

5. Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study;Kiviniemi;Int J Cardiol,2015